环磷酰胺冲击治疗风湿免疫疾病的疗效探讨.docx
《环磷酰胺冲击治疗风湿免疫疾病的疗效探讨.docx》由会员分享,可在线阅读,更多相关《环磷酰胺冲击治疗风湿免疫疾病的疗效探讨.docx(3页珍藏版)》请在三一文库上搜索。
1、环磷酰胺冲击治疗风湿免疫疾病的疗效探讨【摘要】 目的 探讨环磷酰胺(CTX)冲击治疗风湿免疫疾病的临床效果。方法 100例风湿免疫疾病患者, 随机分为对照组与观察组, 各50例。对照组采用羟氯喹、醋酸泼尼松联合甲氨蝶呤治疗, 观察组采用羟氯喹、醋酸泼尼松联合CTX冲击治疗。比较两组的临床效果。结果 观察组晨僵时间(2.09±0.18)h、关节压痛个数(13.4±3.2)个、关节肿胀个数(7.6±2.9)个、血沉(ESR)(40.23±25.41)mm/h、C反应蛋白(CRP)水平(19.87±8.42)mg/L均优于对照组(
2、P0.05)。结论 CTX冲击治疗风湿免疫疾病的效果优于甲氨蝶呤, 可有效缓解症状, 减轻疼痛, 改善临床指标, 且安全性高。【关键词】 风湿免疫疾病;环磷酰胺;冲击治疗DOI:10.14163/ki.11-5547/r.2016.28.013【Abstract】 Objective To investigate clinical effect by cyclophosphamide (CTX) impact therapy for rheumatic and immunological diseases. Methods A total of 100 patients with rheuma
3、tic and immunological diseases were randomly divided into control group and observation group, with 50 cases in each group. The control group received hydroxychloroquine, prednisone acetate combined with methotrexate for treatment, and the observation group received hydroxychloroquine, prednisone ac
4、etate combined with CTX impact therapy. Clinical effects were compared between the two groups. Results The observation group had all better morning stiffness time as (2.09±0.18) h, articular pain as (13.4±3.2) joints, arthrocele as (7.6±2.9) joints, erythrocyte sedimentation rat
5、e (ESR) as (40.23±25.41) mm/h, and C-reactive protein (CRP) level as (19.87±8.42) mg/L than the control group (P0.05). Conclusion CTX impact therapy provides better effect than methotrexate in treating rheumatic and immunological diseases. It can effectively relieve symptom, reduce pai
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 环磷酰胺 冲击 治疗 风湿 免疫 疾病 疗效 探讨
链接地址:https://www.31doc.com/p-9362911.html